Matches in SemOpenAlex for { <https://semopenalex.org/work/W177486562> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W177486562 endingPage "96" @default.
- W177486562 startingPage "389" @default.
- W177486562 abstract "Various consensus groups convened in recent years to discuss plasma volume expansion solutions have suggested limiting the use of human albumin because of its high cost and have favored synthetic crystalloids or colloids for most clinical settings. Dextrans are colloids that are not widely used in most Europeans countries. Gelatins, in spite of the fact that unlimited amounts can be used, produce only moderate volume expansion and can trigger allergic reactions. The availability in Spain of hydroxyethylstarches (HES), a new type of colloid, may significantly change volume replacement strategy. HES are modified natural polymers. Three types, with different initial molecular weights, are used in Europe: high molecular weight HES, whose use in increasingly rare; low molecular weight HES (Expafusin), whose effect is short-lived; and medium molecular weight HES (Elohes, Fresenius-Laboratories Mein), which have recently been registered in Spain. Studies have shown that Elohes 6% (6% HES 200/0.62) provides volume expansion comparable to that of human albumin in clinical settings (cardiac surgery, shock, burns, etc.). The side effects of HES are usually minor. The frequency of anaphylactoid reactions is low, similar to that associated with human albumin. The effects on coagulation depend on molecular weight and duration of HES administration. Only in studies of hemodilution lasting 10 days with 6% HES 200/0.62 has VIII/von Willebrand complex been shown to decrease. If the recommended daily dose of this HES is respected, however, coagulation disorders are minimal. The effect of HES on kidney function is at present a subject of controversy. Thus, thanks to its prolonged effect on volume and few side effects, medium molecular weight HES colloids are the ones most often recommended for use in anesthesia and postoperative intensive care." @default.
- W177486562 created "2016-06-24" @default.
- W177486562 creator A5012826856 @default.
- W177486562 creator A5070531093 @default.
- W177486562 date "1998-11-01" @default.
- W177486562 modified "2023-09-23" @default.
- W177486562 title "[A new hydroxyethyl starch for volume replacement: Elohes 6%]." @default.
- W177486562 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9847657" @default.
- W177486562 hasPublicationYear "1998" @default.
- W177486562 type Work @default.
- W177486562 sameAs 177486562 @default.
- W177486562 citedByCount "3" @default.
- W177486562 crossrefType "journal-article" @default.
- W177486562 hasAuthorship W177486562A5012826856 @default.
- W177486562 hasAuthorship W177486562A5070531093 @default.
- W177486562 hasConcept C104471311 @default.
- W177486562 hasConcept C126322002 @default.
- W177486562 hasConcept C141071460 @default.
- W177486562 hasConcept C147789679 @default.
- W177486562 hasConcept C185592680 @default.
- W177486562 hasConcept C2776125364 @default.
- W177486562 hasConcept C2778382381 @default.
- W177486562 hasConcept C2778597219 @default.
- W177486562 hasConcept C2779412105 @default.
- W177486562 hasConcept C2781300812 @default.
- W177486562 hasConcept C2991747820 @default.
- W177486562 hasConcept C42219234 @default.
- W177486562 hasConcept C55493867 @default.
- W177486562 hasConcept C59789625 @default.
- W177486562 hasConcept C71924100 @default.
- W177486562 hasConceptScore W177486562C104471311 @default.
- W177486562 hasConceptScore W177486562C126322002 @default.
- W177486562 hasConceptScore W177486562C141071460 @default.
- W177486562 hasConceptScore W177486562C147789679 @default.
- W177486562 hasConceptScore W177486562C185592680 @default.
- W177486562 hasConceptScore W177486562C2776125364 @default.
- W177486562 hasConceptScore W177486562C2778382381 @default.
- W177486562 hasConceptScore W177486562C2778597219 @default.
- W177486562 hasConceptScore W177486562C2779412105 @default.
- W177486562 hasConceptScore W177486562C2781300812 @default.
- W177486562 hasConceptScore W177486562C2991747820 @default.
- W177486562 hasConceptScore W177486562C42219234 @default.
- W177486562 hasConceptScore W177486562C55493867 @default.
- W177486562 hasConceptScore W177486562C59789625 @default.
- W177486562 hasConceptScore W177486562C71924100 @default.
- W177486562 hasIssue "9" @default.
- W177486562 hasLocation W1774865621 @default.
- W177486562 hasOpenAccess W177486562 @default.
- W177486562 hasPrimaryLocation W1774865621 @default.
- W177486562 hasRelatedWork W2005922161 @default.
- W177486562 hasRelatedWork W2018013799 @default.
- W177486562 hasRelatedWork W2020285215 @default.
- W177486562 hasRelatedWork W2047835029 @default.
- W177486562 hasRelatedWork W2064532131 @default.
- W177486562 hasRelatedWork W2129857543 @default.
- W177486562 hasRelatedWork W2136990622 @default.
- W177486562 hasRelatedWork W2410726483 @default.
- W177486562 hasRelatedWork W2465756140 @default.
- W177486562 hasRelatedWork W279855145 @default.
- W177486562 hasVolume "45" @default.
- W177486562 isParatext "false" @default.
- W177486562 isRetracted "false" @default.
- W177486562 magId "177486562" @default.
- W177486562 workType "article" @default.